פרדקסה 110 - Pradaxa 110

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××

×§×××¦× ×¤×¨××§××××××ª (ATC4)

B01AE
Direct thrombin inhibitors

××¨××× ×¤×¢×× (ATC5)

Dabigatran etexilate AS MESILATE 110MG âB01AE07

×¦××¨×ª ××ª×

×¤××× - PER OS

×¦××¨×ª ××× ××

×§×¤×¡××××ª, CAPSULES
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation.Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

03/01/2010

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect
×××¤×× ××× ××¢× ×©× ××× ××ª ×©× ×¤×§×§×ª ×××¨×××× ××¢×××§×× (Deep vein thrombosis â DVT).	11/01/2018	×××××××××	DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN
×××¤×× ×§×¦×¨ ×××× ××× ××¢×ª ×©××¥ ××ª×¡×××£ ×¡××¡××× ×××××× ×¢× ×¤×¨×¤××¨ ×¢××××ª ××× ×××× ××¡×ª×××ª ×-CHADS2 score ××¢×¨× 0 ×× 1 ×××¨× ×××¤×× ×§×¦× ××¤×¢××××ª ×©× ××××¦×××ª ××¤×¨×¤××¨	11/01/2018	×××××××××	DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN
×× ××¢×ª ×©××¥ ××ª×¡×××£ ×¡××¡××× ×××××× ×¢× ×¤×¨×¤××¨ ×¢××××ª ××× ×××× ××¡×ª×××ª ×-CHA2DS2 score ××¢×¨× 2 ×××¢××.	21/01/2016	×××××××××	DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN
×× ××¢×ª ×©××¥ ××ª×¡×××£ ×¡××¡××× ×××××× ×¢× ×¤×¨×¤××¨ ×¢××××ª ××× ×××× ××¡×ª×××ª ×-CHA2DS2 score ××¢×¨× 3 ×××¢××.	12/01/2014	×××××××××	DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN
×× ××¢×ª ×©××¥ ××ª×¡×××£ ×¡××¡××× ×××××× ×¢× ×¤×¨×¤××¨ ×¢××××ª ××× ×××× ××¡×ª×××ª ×-CHA2DS2 score ××¢×¨× 4 ×××¢××.	10/01/2012	×××××××××	DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN
×× ××¢×ª ×©××¥ ××ª×¡×××£ ×¡××¡××× ×××××× ×¢× ×¤×¨×¤××¨ ×¢××××ª ×××××¤××× ×-Warfarin ××©×ª××¢× ××¦×× INR ×××× ×-5 ××¤×××ª ×¤×¢×××× ××××× ××©× × ××××¨×× × ××××¨××¢×× × ×¤×¨×××.	23/01/2011	×××××××××	DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN
×× ××¢×ª ×©××¥ ××ª×¡×××£ ×¡××¡××× ×××××× ×¢× ×¤×¨×¤××¨ ×¢××××ª ×××××¤××× ×-warfarin ×××× CVA ×× TIA ×¢× ××××× ×§××× × (×©×××¤× ×× ××××× ××××ª ×××××) ××××× ××©× × ××××¨×× ×.	23/01/2011	×××××××××	DABIGATRAN ETEXILATE, RIVAROXABAN, APIXABAN
×× ××¢×ª ×ª×¨×××××××××××× ××××¨ × ××ª×× ×××××¤×ª ×××¨×.	03/01/2010	×××¨×ª××¤×××	DABIGATRAN ETEXILATE, RIVAROXABAN, APIXABAN
×× ××¢×ª ×ª×¨×××××××××××× ××××¨ × ××ª×× ×××××¤×ª ××¤×¨×§ ×××¨×	03/01/2010	×××¨×ª××¤×××	DABIGATRAN ETEXILATE, RIVAROXABAN, APIXABAN
×× ××¢×ª ×©××¥ ××ª×¡×××£ ×¡××¡××× ×××××× ×¢× ×¤×¨×¤××¨ ×¢××××ª ××× ×××× ××¡×ª×××ª ×-CHA2DS2 VASc score ××¢×¨× 2 ×××¢××.	16/01/2019	×××××××××	DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN
×××¤×× ××× ××¢× ×©× ××× ××ª ×©× ×ª×¡×××£ ×¨×××ª× (Pulmonary embolism - PE).	11/01/2018	×××××××××	DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN

×©××××© ××¡×

××¡××¨×ª ××××× ××¡×

××ª×¨××¤× ×ª×× ×ª× ××××¤×× ×××§×¨×× ××××:

1. ×× ××¢×ª ×ª×¨×××××××××××× ××××¨ × ××ª×× ×××××¤×ª ××¤×¨×§ ×××¨×;

2. ×× ××¢×ª ×ª×¨×××××××××××× ××××¨ × ××ª×× ×××××¤×ª ×××¨×;

3.×× ××¢×ª ×©××¥ ××ª×¡×××£ ×¡××¡××× ×××××× ×¢× ×¤×¨×¤××¨ ×¢××××ª ×××××¤××× ×-warfarin ×××× CVA ×× TIA ×¢× ××××× ×§××× × (×©×××¤× ×× ××××× ××××ª ×××××) ××××× ××©× × ××××¨×× ×

4. ×× ××¢×ª ×©××¥ ××ª×¡×××£ ×¡××¡××× ×××××× ×¢× ×¤×¨×¤××¨ ×¢××××ª ×××××¤××× ×-Warfarin ××©×ª××¢× ××¦×× INR ×××× ×-5 ××¤×××ª ×¤×¢×××× ××××× ××©× × ××××¨×× × ××××¨××¢×× × ×¤×¨×××

5. ×× ××¢×ª ×©××¥ ××ª×¡×××£ ×¡××¡××× ×××××× ×¢× ×¤×¨×¤××¨ ×¢××××ª ××× ×××× ××¡×ª×××ª ×-CHA2DS2 VASc score ××¢×¨× 2 ×××¢××.

6. ×××¤×× ×§×¦×¨ ×××× ××× ××¢×ª ×©××¥ ××ª×¡×××£ ×¡××¡××× ×××××× ×¢× ×¤×¨×¤××¨ ×¢××××ª ××× ×××× ××¡×ª×××ª ×-CHADS2 score ××¢×¨× 0 ×× 1 ×××¨× ×××¤×× ×§×¦× ××¤×¢××××ª ×©× ××××¦×××ª ××¤×¨×¤××¨.

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 30.06.2020

××××¨× ××¢××× 30.06.2020
××××¨× ××¢××× 31.01.2020
××××¨× ××¢××× 24.07.2019
××××¨× ××¢××× 24.07.2019
××××¨× ××¢××× 17.01.2017
××××¨× ××¢××× 12.07.2015 (××¡×× Microsoft Word)
××××¨× ××¢××× ××¨××¤× 10.11.2013 (××¡×× Microsoft Word)
××××¨× ××¢××× 25.12.2012 (××¡×× Microsoft Word)
××××¨× ××¢××× 26.07.2012 (××¡×× Microsoft Word)
××××¨× ××¢××× 30.11.2011 (××¡×× Microsoft Word)

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 30.06.2020 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 30.06.2020 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 31.01.2020 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 30.06.2020 ××¨×××¡ ×××××¤× ×¢××¨××ª 03.10.2019 ××¨×××¡ ×××××¤× ×¢×¨×××ª 03.10.2019 ××¨×××¡ ×××××¤× ×¢×¨×××ª 03.10.2019 ××¨×××¡ ×××××¤× ×¨××¡××ª 03.10.2019

×¢××× ××¦×¨××

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
Â ×¤×¨××§×¡× 110 ×××××¨ ××©×¨× ×××¨××××ª ×¤×¨××§×¡× 110 ×××××¨ ××©×¨× ×××¨××××ª ×¤×¨××§×¡× 110 ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, GERMANY
×©× ××¢× ××¨××©××	BOEHRINGER INGELHEIM ISRAEL LTD.
×¨××©×××	×ª××¨×× ×××©×: 8/2009. ×¨××©××× ××ª××¨××: 02/2015
×ª××¨×× ×¢×××× ×××¨××	14/05/19

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

השינוי האחרון נעשה בֹ־2 ביולי 2021 ב־12:26

פרדקסה 110 - Pradaxa 110

ויקיתרופות